Anti-MRSA agent 14
Anti-MRSA agent 14 (Compound C17) has antibacterial agent against MRSA and MRSA-infected skin murine model. Anti-MRSA agent 14 is more potential than Norfloxacin (HY-B0132) against MRSA. Anti-MRSA agent 14 disrupts cell membrane and restrains metabolism. Anti-MRSA agent 14 shows antibacterial effects against S. aureus ATCC 6538, S. aureus ATCC 29213, S. epidermidis ATCC 12228, and MRSA with MIC values of 1, 2, 2, 1 μM respectively[1].
Product Specifications
CAS Number
[3050586-22-3]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/anti-mrsa-agent-14.html
Smiles
CC1(C)CC[C@]2(C(NS(C3=CC=C(Cl)C=C3)(=O)=O)=O)CC[C@@]4(C)[C@]5(C)CC[C@@]6([H])C(C)(C)C7=C(C(C=CC=C8C(O)=O)=C8N7)C[C@]6(C)[C@@]5([H])CC=C4[C@]2([H])C1
Molecular Formula
C43H53ClN2O5S
Molecular Weight
745.41
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161827/Anti-MRSA-agent-14-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161827/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
